XIST and lung carcinoma: In the context of lung cancer, Li et al. (31) discovered that XIST in metastatic non-small cell lung cancer (NSCLC) tissues facilitates TGF-β-induced EMT, as well as cell invasion and metastasis, through modulation of the miR-367/miR-141-ZEB2 axis.